These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4136228)

  • 21. Serotonergic involvement in behavioural responses to amphetamine at high dosage.
    Lees AJ; Fernando JC; Curzon G
    Neuropharmacology; 1979 Feb; 18(2):153-8. PubMed ID: 431782
    [No Abstract]   [Full Text] [Related]  

  • 22. Alcohol drinking in the rat after destruction of serotonergic and catecholaminergic neurons in the brain.
    Myers RD; Melchior CL
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):363-78. PubMed ID: 1162179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.
    Miller RT; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Mar; 9(2):457-65. PubMed ID: 8839050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some effects of prenatal exposure to d-amphetamine sulfate and phenobarbital on developmental neurochemistry and on behavior.
    Zemp JW; Middaugh LD
    Addict Dis; 1975; 2(1-2):307-31. PubMed ID: 1163369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 26. 5-Hydroxytryptamine in aggressiveness.
    Valzelli L
    Adv Biochem Psychopharmacol; 1974; 11(0):255-63. PubMed ID: 4276860
    [No Abstract]   [Full Text] [Related]  

  • 27. Stereoisomers of viminol: catalepsy and brain monoamine turnover rate.
    Costa E; Cheney D; Revuelta A
    Adv Biochem Psychopharmacol; 1973; 8(0):483-94. PubMed ID: 4800183
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of chlorpromazine and d-amphetamine in Long Evans rats of different age, body weight and brain weight.
    Sofia RD
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):139-46. PubMed ID: 5365229
    [No Abstract]   [Full Text] [Related]  

  • 29. Some effects of the hallucinogenic drug 2, 5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Psychopharmacologia; 1973 Aug; 32(1):33-49. PubMed ID: 4743235
    [No Abstract]   [Full Text] [Related]  

  • 30. Behavioral and neurochemical evaluation of phenylpropanolamine.
    Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of d-amphetamine, morphine and chlorpromazine on responding under fixed-interval schedules of food presentation or electric shock presentation.
    McKearney JW
    J Pharmacol Exp Ther; 1974 Jul; 190(1):141-53. PubMed ID: 4211164
    [No Abstract]   [Full Text] [Related]  

  • 32. LH syndrome and brain catecholamine levels after lesions of the nigrostriatal bundle.
    Oltmans GA; Harvey JA
    Physiol Behav; 1972 Jan; 8(1):69-78. PubMed ID: 4665334
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 34. The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat.
    Pearl RG; Seiden LS
    J Pharmacol Exp Ther; 1976 Sep; 198(3):635-47. PubMed ID: 978464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral effects of serotonergic and dopaminergic drugs in cats following chronic amphetamine administration.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1984 Apr; 99(4):313-24. PubMed ID: 6734730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
    Snyder SH
    Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of acrylamide on locomotion and central monoamine function in the rat.
    Rafales LS; Lasley SM; Greenland RD; Mandybur T
    Pharmacol Biochem Behav; 1983 Oct; 19(4):635-44. PubMed ID: 6647502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-stimulation reward pathways: norepinephrine vs dopamine.
    Stein L; Belluzzi JD; Ritter S; Wise CD
    J Psychiatr Res; 1974; 11():115-24. PubMed ID: 4461783
    [No Abstract]   [Full Text] [Related]  

  • 39. Depletion of hypothalamic norepinephrine by food deprivation and interaction with D-amphetamine.
    Glick SD; Waters DH; Milloy S
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):775-8. PubMed ID: 4750114
    [No Abstract]   [Full Text] [Related]  

  • 40. The roles of monoamine neural systems in the anorexia induced by(+)-amphetamine and related compounds.
    Hollister AS; Ervin GN; Cooper BR; Breese GR
    Neuropharmacology; 1975 Oct; 14(10):715-23. PubMed ID: 1196470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.